Patents Assigned to Biogenesys
  • Use of methyl donor compounds to treat neurological dysfunction associated with immune defects
    Patent number: 5716941
    Abstract: A method for treating a mammal with a demyelinating disease associated with an immunological disorder comprising administering methylcobalamin or cyanocobalamin.
    Type: Grant
    Filed: March 29, 1996
    Date of Patent: February 10, 1998
    Assignee: Biogenesys
    Inventor: Michael Rabinoff
  • Treatment of neurological dysfunction with methylcobalamin
    Patent number: 5508271
    Abstract: A method for treating neurological dysfunctions associated with AIDS or ARC comprising the administration of methylcobalamin, alone or in combination with methionine. Substantial increases in the number of T4+ T-lymphocytes, T8+ T-lymphocytes, or the ratio of T4+ to T8+ T-lymphocytes is also observed with this treatment.
    Type: Grant
    Filed: July 7, 1993
    Date of Patent: April 16, 1996
    Assignee: Biogenesys
    Inventor: Michael Rabinoff